October 9, 2020 Webinar: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis (Sept.18, 2020)
October 9, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute
September 17, 2020 C-Path Launches Consortium to Accelerate Medical Product Development in Sickle Cell Disease September is National Sickle Cell Awareness Month TUCSON, Ariz., Sept. 17, 2020 — The Critical Path Institute (C-Path) today
September 13, 2020 The Critical Path Institute: 15 Years of Impact A catalyst in the development of new tools and approaches to advance regulatory science and medical product developm
September 13, 2020 Drug Development and Regulation in the Age of Precision Medicine An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory sci
September 13, 2020 New Uses for Existing Drugs: Applications for COVID-19 and Valley Fever What is drug repurposing and why is it important? Learn more about the CURE ID web-based app made possible by the National Center
September 13, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute This presentation focuses on the bridge between a person’s ultimate health in light of being affected by a debilitating disease,
September 9, 2020 C-Path Awarded FDA Drug Development Tool Research Grant to Develop a Qualification Plan for the Symptoms of Major Depressive Disorder Momentary Assessment (SMDDMA) C-Path’s Patient-Reported Outcome (PRO) Consortium announced that it has been awarded a U.S. Food and Drug Administration (FDA)
September 6, 2020 Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19 This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
